STAAR Surgical Co Debt Securities, Available-for-sale, Sold at Par Value
STAAR Surgical Co (STAA) reported Debt Securities, Available-for-sale, Sold at Par Value of $1.95 million for the 6-month period ending 2026-07-03, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Debt and Equity Securities
us-gaap:AvailableforsaleSecuritiesSoldAtPar · last filed 2026-08-12
- STAAR Surgical Co debt securities, available-for-sale, sold at par value for the quarter ending 2026-07-03 was $300.00K, a 40.00% decline year-over-year.
- STAAR Surgical Co debt securities, available-for-sale, sold at par value for the quarter ending 2026-04-03 was $1.65M, a 355.80% increase year-over-year.
- STAAR Surgical Co debt securities, available-for-sale, sold at par value for the quarter ending 2026-01-02 was $0.00, a 100.00% decline year-over-year.
- STAAR Surgical Co debt securities, available-for-sale, sold at par value for the quarter ending 2025-09-26 was $2.52M.
- STAAR Surgical Co debt securities, available-for-sale, sold at par value for fiscal 2026 was $3.38M, a 157.00% increase from fiscal 2024.
- STAAR Surgical Co debt securities, available-for-sale, sold at par value for fiscal 2024 was $1.31M, a 1.08% increase from fiscal 2023.
- STAAR Surgical Co debt securities, available-for-sale, sold at par value for fiscal 2023 was $1.30M, a 262.12% increase from fiscal 2022.
- STAAR Surgical Co debt securities, available-for-sale, sold at par value for fiscal 2022 was $359.00K.
| Period end | Debt Securities, Available-for-sale, Sold at Par Value 3 month | Debt Securities, Available-for-sale, Sold at Par Value 6 month | Debt Securities, Available-for-sale, Sold at Par Value 9 month | Debt Securities, Available-for-sale, Sold at Par Value 12 month |
|---|---|---|---|---|
| 2026-07-03 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $1.95M 10-Q · filed 2026-08-12 | $1.95M derived: sum of 3 quarters · filed 2026-08-12 | $4.46M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-04-03 | $1.65M 10-Q · filed 2026-05-13 | $1.65M derived: sum of 2 quarters · filed 2026-05-13 | $4.17M derived: sum of 3 quarters · filed 2026-05-13 | $4.67M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-01-02 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $2.52M derived: sum of 2 quarters · filed 2026-03-03 | $3.02M derived: sum of 3 quarters · filed 2026-08-12 | $3.38M 10-K · filed 2026-03-03 |
| 2025-09-26 | $2.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.02M derived: sum of 2 quarters · filed 2026-08-12 | $3.38M 10-Q · filed 2025-11-05 | $3.84M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-27 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $862.00K 10-Q · filed 2026-08-12 | $1.33M derived: sum of 3 quarters · filed 2026-08-12 | $1.33M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-28 | $362.00K 10-Q · filed 2026-05-13 | $826.00K derived: sum of 2 quarters · filed 2026-05-13 | $826.00K derived: sum of 3 quarters · filed 2026-05-13 | $826.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-27 | $464.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $464.00K derived: sum of 2 quarters · filed 2026-03-03 | $464.00K derived: sum of 3 quarters · filed 2026-03-03 | $1.31M 10-K · filed 2026-03-03 |
| 2024-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $850.00K 10-Q · filed 2025-11-05 | $1.55M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $850.00K 10-Q · filed 2025-08-06 | $1.55M derived: sum of 3 quarters · filed 2026-03-03 | $1.55M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-29 | $850.00K 10-Q · filed 2025-05-07 | $1.55M derived: sum of 2 quarters · filed 2026-03-03 | $1.55M derived: sum of 3 quarters · filed 2026-03-03 | $1.55M derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-29 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $700.00K derived: sum of 2 quarters · filed 2026-03-03 | $700.00K derived: sum of 3 quarters · filed 2026-03-03 | $1.30M 10-K · filed 2024-02-27 |
| 2023-09-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $0.00 derived: sum of 2 quarters · filed 2024-10-30 | $600.00K 10-Q · filed 2024-10-30 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $600.00K 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | $600.00K 10-Q · filed 2024-05-07 | |||
| 2022-12-30 | $359.00K 10-K · filed 2025-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |